Clinical Trials Directory

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

Coronary Laser in Undilatable or Uncrossable Lesions

Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy

Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade

NCI COVID-19 in Cancer Patients, NCCAPS Study

Pre-operative RadiothErapy for Soft Tissue SarcOmas

"Study to Compare AMG 510 Proposed INN Sotorasib With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200)."

SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer

A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma

Neoadjuvant RCT Versus CT for Patients With Locally Advanced, Potentially Resectable Adenocarcinoma of the GEJ

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Burden for STaff Working in the NHS

Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments

Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers

The Pittsburgh Study Early Childhood

COPE - COVID-19 in Pregnancy and Early Childhood

Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia

Low Intensity Shockwave Therapy for Erectile Dysfunction

Different Limb Lengths in Gastric Bypass Surgery

Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia

Blended Treatment for Alcohol Use Disorder

Endocrine Disrupting Chemical Exposure and Testicular Cancer

Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)

Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis

Sacrocolpopexy and Lateral Suspension Operations

Tocilizumab Treatment in Patients With COVID-19

Shockwave Therapy for Plantar Fasciitis RCT

"Sleep Patterns and EEG Structure in Youth With Autism: Links With Behavior and Parental Stress"

Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment

Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism

Bevacizumab Plus MFOLFOXIRI As First-line Treatment for Patients with Unresectable Metastatic Colorectal Cancer

Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression

Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value

Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.

Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value

INTREPId (INTermediate Risk Erection PreservatIon Trial)

Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Association of Centre of Excellence Self- Administered Questionnaire Score and Frailty Levels

Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment

Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

Lifestyles and Breast Cancer

Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors

PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer